.pf{position:relative;background-color:#fff;overflow:hidden;margin:0;border:0}.pc{position:absolute;border:0;padding:0;margin:0;top:0;left:0;width:100%;height:100%;overflow:hidden;display:block;transform-origin:0 0;-ms-transform-origin:0 0;-webkit-transform-origin:0 0}.bi{position:absolute;border:0;margin:0}.c{position:absolute;border:0;padding:0;margin:0;overflow:hidden;display:block}.t{position:absolute;white-space:pre;font-size:1px;transform-origin:0 100%;-ms-transform-origin:0 100%;-webkit-transform-origin:0 100%;unicode-bidi:bidi-override;-moz-font-feature-settings:"liga" 0}.t:after{content:''}.t:before{content:'';display:inline-block}.t span{position:relative;unicode-bidi:bidi-override}._{display:inline-block;color:transparent;z-index:-1}.pi{display:none}@media screen{.pf{margin:13px auto;box-shadow:1px 1px 3px 1px #333;border-collapse:separate}}.ff1{font-family:ff1;line-height:.958008;font-style:normal;font-weight:400;visibility:visible}.ff2{font-family:ff2;line-height:.959473;font-style:normal;font-weight:400;visibility:visible}@font-face{font-family:ff3;src:url(data:application/font-woff;base64,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) format("woff")}.ff3{font-family:ff3;line-height:.734;font-style:normal;font-weight:400;visibility:visible}.m0{transform:matrix(.320260,0,0,.320260,0,0);-ms-transform:matrix(.320260,0,0,.320260,0,0);-webkit-transform:matrix(.320260,0,0,.320260,0,0)}.v2{vertical-align:-3.6628px}.v1{vertical-align:4.3372px}.ls5{letter-spacing:0}.ls1{letter-spacing:.008800px}.ls0{letter-spacing:.009600px}.ls6{letter-spacing:1.12px}.ls4{letter-spacing:25.52px}.ls3{letter-spacing:26.4176px}.ls2{letter-spacing:29.52px}.sc0{text-shadow:-.015em 0 transparent,0 .015em transparent,.015em 0 transparent,0 -.015em transparent}@media screen and (-webkit-min-device-pixel-ratio:0){.sc0{-webkit-text-stroke:.015em transparent;text-shadow:none}}.ws1{word-spacing:-12.240800px}.ws0{word-spacing:-12.232px}.ws3{word-spacing:0}._0{margin-left:-3.5568px}._1{margin-left:-1.122px}.fc1{color:#444}.fc0{color:#000}.fs3{font-size:44px}.fs0{font-size:48px}.fs4{font-size:52.8px}.fs2{font-size:56px}.fs1{font-size:72px}.y0{bottom:0}.y2{bottom:7.378543px}.y2a{bottom:25.512891px}.y29{bottom:42.16638px}.y28{bottom:57.64687px}.y27{bottom:74.300411px}.y26{bottom:92.127001px}.y3{bottom:92.234993px}.y25{bottom:107.607491px}.y24{bottom:124.261032px}.y23{bottom:142.087622px}.y22{bottom:174.221653px}.y21{bottom:207.528734px}.y20{bottom:222.793241px}.y1f{bottom:240.835814px}.y1e{bottom:256.100321px}.y1d{bottom:274.142895px}.y1c{bottom:291.969485px}.y1b{bottom:307.449976px}.y1a{bottom:322.714483px}.y19{bottom:340.757056px}.y18{bottom:356.021563px}.y17{bottom:375.237187px}.y16{bottom:390.717677px}.y15{bottom:405.982184px}.y14{bottom:425.197808px}.y13{bottom:457.331839px}.y12{bottom:490.638919px}.y11{bottom:505.903426px}.y10{bottom:523.946px}.yf{bottom:539.210507px}.ye{bottom:555.864048px}.yd{bottom:577.749746px}.yc{bottom:605.93266px}.yb{bottom:639.239741px}.ya{bottom:655.893281px}.y9{bottom:672.546822px}.y8{bottom:689.200362px}.y7{bottom:705.853902px}.y6{bottom:722.507443px}.y5{bottom:746.847233px}.y4{bottom:796.807854px}.y1{bottom:916.252169px}.h1{height:25.620831px}.h6{height:32.419922px}.h7{height:32.634766px}.h2{height:35.367188px}.h8{height:38.903906px}.h5{height:40.32px}.h4{height:53.402344px}.h3{height:825.733772px}.h0{height:1014.58492px}.w1{width:181.314908px}.w2{width:613.445713px}.w0{width:783.997438px}.x0{left:0}.x2{left:5.124166px}.x6{left:19.856144px}.x4{left:21.137186px}.x5{left:35.228643px}.x3{left:86.470306px}.x1{left:514.290662px}

PHAR 100 Final: Final Exam Study Guide that Covers Module 1-6 (Comprehensive)

Canada

Introductory Pharmacology

Pharmacology and Toxicology

Bill Racz

Queen's University

The Study of Personality

PHAR 100 Study Guide - Final Guide: Ephedra, Vaginal Bleeding, Ergometrine

PHAR 100 Lecture Notes - Lecture 1: Physostigma Venenosum, Ergot, Ephedra

[PHAR 100] - Final Exam Guide - Everything you need to know! (84 pages long)

All Subjects

Accounting

Mathematics

Statistics

Computer Science

Calculus

Psychology

Management

Biology

Physics

Chemistry

Electrical Engineering

Mechanical Engineering

Marketing

Music

History

Project Management

Business

Architecture

Geography

Science

Nursing

Information Technology

Engineering

English

Finance

Philosophy

Astronomy

Communications

Sociology

Anthropology

Prealgebra

Algebra

Precalculus

Ethics

Geometry

Probability

Economics

PHAR 100 Final: Final Exam Study Guide that Covers Module 1-6 (Comprehensive)

Get access

Related Documents

PHAR 100 Study Guide - Final Guide: Ephedra, Vaginal Bleeding, Ergometrine

PHAR 100 Lecture Notes - Lecture 1: Physostigma Venenosum, Ergot, Ephedra

[PHAR 100] - Final Exam Guide - Everything you need to know! (84 pages long)